(Q40273062)

19 September 2017

Physostigmine, but not neostigmine, inhibits acetylcholine release (English)

1 reference

https://api.crossref.org/works/10.1016/0006-8993(79)90721-2

18 January 2023

1 reference

M. T. Alderdice

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A228798

18 January 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=228798

18 January 2023

publication date

1 December 1979

1 reference

19 September 2017

14 December 1979

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=228798

full work available at URL

18 January 2023

https://api.elsevier.com/content/article/PII:0006899379907212?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-8993(79)90721-2

https://api.elsevier.com/content/article/PII:0006899379907212?httpAccept=text/plain

18 January 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(79)90721-2

18 January 2023

1 reference

19 September 2017

178

1 reference

19 September 2017

2-3

1 reference

19 September 2017

596-599

1 reference

Cholinergic and dopaminergic mechanisms in Huntington's chorea

19 September 2017

2

1 reference

https://api.crossref.org/works/10.1016/0006-8993(79)90721-2

Pharmacological characterization of tardive dyskinesia

18 January 2023

3

1 reference

https://api.crossref.org/works/10.1016/0006-8993(79)90721-2

Choline in tardive dyskinesia and Huntington's disease

18 January 2023

4

1 reference

https://api.crossref.org/works/10.1016/0006-8993(79)90721-2

Quantal components of the end-plate potential

18 January 2023

5

1 reference

https://api.crossref.org/works/10.1016/0006-8993(79)90721-2

Cholinergic suppression of tardive dyskinesia

18 January 2023

7

1 reference

https://api.crossref.org/works/10.1016/0006-8993(79)90721-2

Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia

18 January 2023

8

1 reference

https://api.crossref.org/works/10.1016/0006-8993(79)90721-2

On the factors which determine the amplitude of the miniature end-plate potential

18 January 2023

9

1 reference

https://api.crossref.org/works/10.1016/0006-8993(79)90721-2

The pharmacology of tardive dyskinesias

18 January 2023

10

1 reference

https://api.crossref.org/works/10.1016/0006-8993(79)90721-2

Central cholinergic-anticholinergic antagonism in Huntington's chorea

18 January 2023

11

1 reference

https://api.crossref.org/works/10.1016/0006-8993(79)90721-2

Effect of cholinergic and anticholinergic agents on tardive dyskinesia

18 January 2023

12

1 reference

https://api.crossref.org/works/10.1016/0006-8993(79)90721-2

A further study of the statistical composition on the end-plate potential

18 January 2023

13

1 reference

https://api.crossref.org/works/10.1016/0006-8993(79)90721-2

18 January 2023

Huntington's chorea

14

1 reference

https://api.crossref.org/works/10.1016/0006-8993(79)90721-2

Physostigmine in choreiform movement disorders

18 January 2023

15

1 reference

https://api.crossref.org/works/10.1016/0006-8993(79)90721-2

The direct action of prostigmine on skeletal muscle; its relationship to the choline esters

18 January 2023

17

1 reference

https://api.crossref.org/works/10.1016/0006-8993(79)90721-2

18 January 2023

Identifiers

1 reference

19 September 2017

1 reference